04/28/2026
We’re excited to share that Zevra Therapeutics was featured in PharmaBoardroom’s recent rare disease addition.
The feature brings together key voices across the U.S. Food and Drug Administration, National Institutes of Health, policy and advocacy leaders, leading research institutions, and industry executives, all focused on advancing progress for the rare disease community.
We’re honored to be included among stakeholders working to drive innovation, collaboration, and meaningful impact for patients and families.
Read the full article here: https://pharmaboardroom.com/articles/spearheading-the-charge-against-rare-disease/